Stocksigma LogoStocksigma Logo

Procter & Gamble Health Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

■ Revenue: 38,249 (+17.7% YoY | +5.2% QoQ) ■ EBITDA: 15,237 (+26.7% YoY | +53.0% QoQ) ■ EBITDA Margin (%): 39.8 (+282 bps YoY | +1245 bps QoQ) ■ PAT

Procter & Gamble Health Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

Procter & Gamble Health Ltd · Outcome · 02 Nov 2026, 8:13 pm

Procter & Gamble Health Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 38,249 (+17.7% YoY | +5.2% QoQ) ■ EBITDA: 15,237 (+26.7% YoY | +53.0% QoQ) ■ EBITDA Margin (%): 39.8 (+282 bps YoY | +1245 bps QoQ) ■ PAT: 11,151 (+25.9% YoY | +16.0% QoQ) ■ EPS (INR): 67.2 (+25.9% YoY | +73.3% QoQ)

Original exchange filing (PDF)

More announcements from Procter & Gamble Health Ltd

All Procter & Gamble Health Ltd announcements